In this context, higher GDF15 in T2DM patients with atherosclerosis and thrombotic complications could be a compensatory mechanism against reverse oxidative and inflammatory‐induced thrombotic disorders. This evidence concerns the gene GDF15 and type 2 diabetes mellitus.